BsAUC for insulin during insulin-induced hypoglycemia was slightly but significantly lower during GLP-2 infusion compared to placebo (28.8 ± 2.8 [placebo] vs 24.4 ± 4.1 nmol/L × min [GLP-2]; P  < .005) (see Fig. 2J, Table 3). This evidence concerns the gene INS and Hypoglycemia.